Avectas Limited

Ireland

Back to Profile

1-50 of 50 for Avectas Limited Sort by
Query
Aggregations
IP Type
        Patent 43
        Trademark 7
Jurisdiction
        United States 23
        World 15
        Canada 8
        Europe 4
Date
2025 April 1
2025 March 1
2025 (YTD) 3
2024 4
2023 2
See more
IPC Class
C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation 27
C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave 20
C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides 17
C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells 15
C07K 14/725 - T-cell receptors 8
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 7
09 - Scientific and electric apparatus and instruments 7
10 - Medical apparatus and instruments 7
42 - Scientific, technological and industrial services, research and design 7
01 - Chemical and biological materials for industrial, scientific and agricultural use 5
Status
Pending 18
Registered / In Force 32

1.

TRANSFECTION OF CELLS VIA REVERSIBLE PERMEABILIZATION

      
Application Number IB2024059886
Publication Number 2025/078978
Status In Force
Filing Date 2024-10-09
Publication Date 2025-04-17
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Martin, Darren
  • Hackett, Emer

Abstract

The current subject matter provides a cell engineering platform for vector-free and/or viral delivery of payload/cargo compounds and compositions into cells. The platform achieves delivery to cells quickly and in an easy to use manner in an increased environmental temperature. A population of adherent cells is contacted with an aqueous solution including a payload and an alcohol at a concentration (v/v) greater than 2% in an environment having a temperature greater than 25°C. Also provided herein are non-viral methods for reprogramming blood cells to induced pluripotent stem cells (iPSCs). Related apparatus, systems, techniques, articles and compositions are also described.

IPC Classes  ?

  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

2.

VECTOR-FREE INTRACELLULAR DELIVERY BY REVERSIBLE PERMEABILISATION

      
Application Number 18760260
Status Pending
Filing Date 2024-07-01
First Publication Date 2025-03-27
Owner Avectas Limited (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The invention provides a solution to the problem of transfecting non-adherent cells. Devices and delivery compositions containing ethanol and an isotonic salt solution are used for delivery of compounds and compositions to non-adherent cells.

IPC Classes  ?

  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • B01J 19/00 - Chemical, physical or physico-chemical processes in generalTheir relevant apparatus
  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
  • C07K 14/725 - T-cell receptors
  • C12M 1/00 - Apparatus for enzymology or microbiology
  • C12M 1/32 - Inoculator or sampler multiple field or continuous type
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus
  • C12M 3/02 - Tissue, human, animal or plant cell, or virus culture apparatus with means providing suspensions
  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
  • C12N 13/00 - Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

3.

PAYLOAD DELIVERY ACROSS CELL MEMBRANES USING CONTINUOUS FLOW FLUIDIC SYSTEM

      
Application Number 18817682
Status Pending
Filing Date 2024-08-28
First Publication Date 2025-02-20
Owner Avectas Limited (Ireland)
Inventor Maguire, Michael

Abstract

Methods, systems, processes, and apparatuses are provided for delivery across cell membranes. In one aspect, an apparatus includes a substrate including a mixing channel, a process chamber, and a dilution channel to perform delivery of the payload to across the cell membranes. In another aspect, a system includes reservoirs for a cell suspension, a delivery solution, and a stop solution connected to a pump. The system further includes an agitator, a heater, a temperature controller, and a controller to operate the system. In yet another aspect, cells in suspension are mixed with a delivery solution in a microfluidic mixing chip. The delivery solution includes a permeabilization agent to cause permeabilization of the cells, allowing delivery of a payload from the delivery solution to the cells across the cell membranes.

IPC Classes  ?

  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells

4.

VECTOR-FREE DELIVERY OF GENE EDITING PROTEINS AND COMPOSITIONS TO CELLS AND TISSUES

      
Application Number 18509634
Status Pending
Filing Date 2023-11-15
First Publication Date 2024-08-22
Owner Avectas Limited (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The present subject matter provides a method for delivering a gene editing composition across a plasma membrane of a cell. Related apparatus, system, techniques, compositions, and articles are also described.

IPC Classes  ?

  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
  • B01L 5/00 - Gas handling apparatus
  • C12N 9/22 - Ribonucleases
  • C12N 15/11 - DNA or RNA fragmentsModified forms thereof
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

5.

SPRAY NOZZLE

      
Application Number 18393936
Status Pending
Filing Date 2023-12-22
First Publication Date 2024-08-08
Owner Avectas Limited (Ireland)
Inventor
  • Pearson, Alan Patrick
  • Finnegan, Shane
  • Cox, Simon Peter
  • Jobanputra, Rishi Dhanvantray
  • Taylor, Donal Joseph
  • Rubiconi, Franck Joseph Dorien

Abstract

An apparatus is provided. The apparatus can include a housing having a first end and a second end. The first end can include a sample inlet and a gas inlet. The second end can include a sample outlet and a gas outlet. The apparatus can also include a sample delivery passage extending within the housing and fluidically coupling the sample inlet to the sample outlet. The apparatus can also include a gas delivery passage extending within the housing and fluidically coupling the gas inlet to the gas outlet. Systems and methods including the apparatus are also provided herein.

IPC Classes  ?

  • C12M 1/00 - Apparatus for enzymology or microbiology
  • G01N 1/38 - Diluting, dispersing or mixing samples

6.

SEQUENTIAL DELIVERY OF RNPS TO IMMUNE CELLS

      
Application Number 18272699
Status Pending
Filing Date 2022-01-20
First Publication Date 2024-05-23
Owner Avectas Limited (Ireland)
Inventor
  • O'Dea, Shirley
  • Maguire, Michael

Abstract

The invention provides a solution to the problem of transfecting non-adherent cells. Methods and compositions containing ethanol and an isotonic salt solution are used for delivery of compounds and compositions to mammalian cells.

IPC Classes  ?

  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
  • C07K 14/705 - ReceptorsCell surface antigensCell surface determinants
  • C07K 14/725 - T-cell receptors
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

7.

DELIVERY PLATFORM

      
Application Number 18263359
Status Pending
Filing Date 2022-02-01
First Publication Date 2024-04-04
Owner Avectas Limited (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The current subject matter provides a cell engineering platform for vector-free and/or viral delivery of payload/cargo compounds and compositions into cells. The platform achieves delivery to cells quickly and in an easy to use manner. Related apparatus, systems, techniques, articles and compositions are also described.

IPC Classes  ?

  • C12M 1/26 - Inoculator or sampler
  • C12M 1/00 - Apparatus for enzymology or microbiology
  • C12M 1/12 - Apparatus for enzymology or microbiology with sterilisation, filtration, or dialysis means
  • C12M 1/36 - Apparatus for enzymology or microbiology including condition or time responsive control, e.g. automatically controlled fermentors
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12M 3/06 - Tissue, human, animal or plant cell, or virus culture apparatus with filtration, ultrafiltration, inverse osmosis or dialysis means

8.

AVECTAS

      
Serial Number 98141953
Status Registered
Filing Date 2023-08-21
Registration Date 2024-08-13
Owner Avectas Limited (Ireland)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Stem cells for research purposes Pharmaceutical preparations for the treatment of immune-oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; stem cells for medical purposes; living cells for medical use Scientific apparatus and instruments, namely, scientific apparatus and instruments for the transfer of biological molecules into living cells; measuring apparatus and instruments, namely, pressure measuring apparatus; probes for scientific purposes, namely, ultrasound probes, not for medical use; bioassay apparatus, namely, pressure measuring apparatus for use in bioassay techniques other than medical; replacement parts and fittings for the aforesaid goods Surgical apparatus and instruments; medical apparatus and instruments for delivery of macro molecules to the mouth, nose, airway, lungs; veterinary apparatus and instruments, namely, catheter for veterinary purposes; medical and surgical probes; probes for medical use and medical diagnostic purposes; medical heartbeat measuring apparatus for use in bioassay techniques; replacement parts and fittings for the aforesaid goods; measuring apparatus and instruments, namely, heartbeat measuring apparatus Scientific and technological services, namely, research and design in the field of pharmaceutics, tissue engineering and regenerative medicine; analysis of industrial fluids and scientific research services; medical and scientific research; pharmaceutical research and development, and clinical testing, namely, conducting clinical trials for others in the field of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of probes, reagents and bioassays for industrial and scientific purposes; advisory, consultancy and information services relating to the provision of the aforesaid

9.

avectas

      
Application Number 018839565
Status Registered
Filing Date 2023-02-22
Registration Date 2023-07-20
Owner Avectas Limited (Ireland)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Stem cells for research purposes. Pharmaceutical preparations for the treatment of immune-oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; stem cells for medical purposes; living cells for medical use. Scientific apparatus and instruments, namely, scientific apparatus and instruments for the transfer of biological molecules into living cells; measuring apparatus and instruments, namely, pressure measuring apparatus; probes for scientific purposes, namely, ultrasound probes, not for medical use; bioassay apparatus, namely, pressure measuring apparatus for use in bioassay techniques other than medical; replacement parts and fittings for the aforesaid goods. Surgical apparatus and instruments; medical apparatus and instruments for delivery of macro molecules to the mouth, nose, airway, lungs; veterinary apparatus and instruments, namely, catheter for veterinary purposes; medical and surgical probes; probes for medical use and medical diagnostic purposes; medical heartbeat measuring apparatus for use in bioassay techniques; replacement parts and fittings for the aforesaid goods; measuring apparatus and instruments, namely, heartbeat measuring apparatus. Scientific and technological services, namely, research and design in the field of pharmaceutics, tissue engineering and regenerative medicine; analysis of industrial fluids and scientific research services; medical and scientific research; pharmaceutical research and development, and clinical testing, namely, conducting clinical trials for others in the field of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of probes, reagents and bioassays for industrial and scientific purposes; advisory, consultancy and information services relating to the provision of the aforesaid.

10.

SPRAY NOZZLE

      
Document Number 03225582
Status Pending
Filing Date 2022-06-24
Open to Public Date 2022-12-29
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Pearson, Alan Patrick
  • Finnegan, Shane
  • Cox, Simon Peter
  • Jobanputra, Rishi Dhanvantray
  • Taylor, Donal Joseph
  • Rubiconi, Franck Joseph Dorien

Abstract

An apparatus is provided. The apparatus can include a housing having a first end and a second end. The first end can include a sample inlet and a gas inlet. The second end can include a sample outlet and a gas outlet. The apparatus can also include a sample delivery passage extending within the housing and fluidically coupling the sample inlet to the sample outlet. The apparatus can also include a gas delivery passage extending within the housing and fluidically coupling the gas inlet to the gas outlet. Systems and methods including the apparatus are also provided herein.

IPC Classes  ?

  • A61M 5/30 - Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or cartridges
  • B05B 1/02 - Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave

11.

SPRAY NOZZLE

      
Application Number IB2022055905
Publication Number 2022/269570
Status In Force
Filing Date 2022-06-24
Publication Date 2022-12-29
Owner AVECTAS LIMITED (Ireland)
Inventor Pearson, Alan Patrick

Abstract

An apparatus is provided. The apparatus can include a housing having a first end and a second end. The first end can include a sample inlet and a gas inlet. The second end can include a sample outlet and a gas outlet. The apparatus can also include a sample delivery passage extending within the housing and fluidically coupling the sample inlet to the sample outlet. The apparatus can also include a gas delivery passage extending within the housing and fluidically coupling the gas inlet to the gas outlet. Systems and methods including the apparatus are also provided herein.

IPC Classes  ?

  • A61M 5/30 - Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or cartridges
  • B05B 1/02 - Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave

12.

DELIVERY PLATFORM

      
Application Number IB2022050876
Publication Number 2022/162646
Status In Force
Filing Date 2022-02-01
Publication Date 2022-08-04
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The current subject matter provides a cell engineering platform for vector-free and/or viral delivery of payload/cargo compounds and compositions into cells. The platform achieves delivery to cells quickly and in an easy to use manner. Related apparatus, systems, techniques, articles and compositions are also described.

IPC Classes  ?

  • C12M 1/32 - Inoculator or sampler multiple field or continuous type
  • C12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus
  • C12M 1/12 - Apparatus for enzymology or microbiology with sterilisation, filtration, or dialysis means
  • C12M 3/06 - Tissue, human, animal or plant cell, or virus culture apparatus with filtration, ultrafiltration, inverse osmosis or dialysis means
  • C12M 1/00 - Apparatus for enzymology or microbiology
  • C12M 1/26 - Inoculator or sampler
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12M 1/34 - Measuring or testing with condition measuring or sensing means, e.g. colony counters
  • C12M 1/36 - Apparatus for enzymology or microbiology including condition or time responsive control, e.g. automatically controlled fermentors

13.

DELIVERY PLATFORM

      
Document Number 03206787
Status Pending
Filing Date 2022-02-01
Open to Public Date 2022-08-04
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The current subject matter provides a cell engineering platform for vector-free and/or viral delivery of payload/cargo compounds and compositions into cells. The platform achieves delivery to cells quickly and in an easy to use manner. Related apparatus, systems, techniques, articles and compositions are also described.

IPC Classes  ?

  • C12M 1/32 - Inoculator or sampler multiple field or continuous type

14.

SEQUENTIAL DELIVERY OF RNPS TO IMMUNE CELLS

      
Document Number 03204660
Status Pending
Filing Date 2022-01-20
Open to Public Date 2022-07-28
Owner AVECTAS LIMITED (Ireland)
Inventor
  • O'Dea, Shirley
  • Maguire, Michael

Abstract

The invention provides a solution to the problem of transfecting non-adherent cells. Methods and compositions containing ethanol and an isotonic salt solution are used for delivery of compounds and compositions to mammalian cells.

IPC Classes  ?

  • A61K 35/17 - LymphocytesB-cellsT-cellsNatural killer cellsInterferon-activated or cytokine-activated lymphocytes
  • C07K 14/705 - ReceptorsCell surface antigensCell surface determinants
  • C07K 14/725 - T-cell receptors
  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

15.

METHODS OF VIRAL DELIVERY TO A POPULATION OF CELLS

      
Application Number 17615081
Status Pending
Filing Date 2020-05-30
First Publication Date 2022-07-28
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The invention provides a method of viral transfection of cells.

IPC Classes  ?

  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
  • C12N 15/86 - Viral vectors
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

16.

SEQUENTIAL DELIVERY OF RNPS TO IMMUNE CELLS

      
Application Number IB2022050492
Publication Number 2022/157671
Status In Force
Filing Date 2022-01-20
Publication Date 2022-07-28
Owner AVECTAS LIMITED (Ireland)
Inventor
  • O'Dea, Shirley
  • Maguire, Michael

Abstract

The invention provides a solution to the problem of transfecting non-adherent cells. Methods and compositions containing ethanol and an isotonic salt solution are used for delivery of compounds and compositions to mammalian cells.

IPC Classes  ?

  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C07K 14/725 - T-cell receptors
  • C07K 14/705 - ReceptorsCell surface antigensCell surface determinants
  • A61K 35/17 - LymphocytesB-cellsT-cellsNatural killer cellsInterferon-activated or cytokine-activated lymphocytes

17.

Vector-free intracellular delivery by reversible permeabilisation

      
Application Number 17337165
Grant Number 12060570
Status In Force
Filing Date 2021-06-02
First Publication Date 2021-11-25
Grant Date 2024-08-13
Owner Avectas Limited (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The invention provides a solution to the problem of transfecting non-adherent cells. Devices and delivery compositions containing ethanol and an isotonic salt solution are used for delivery of compounds and compositions to non-adherent cells.

IPC Classes  ?

  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • B01J 19/00 - Chemical, physical or physico-chemical processes in generalTheir relevant apparatus
  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
  • C07K 14/725 - T-cell receptors
  • C12M 1/00 - Apparatus for enzymology or microbiology
  • C12M 1/32 - Inoculator or sampler multiple field or continuous type
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus
  • C12M 3/02 - Tissue, human, animal or plant cell, or virus culture apparatus with means providing suspensions
  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
  • C12N 13/00 - Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

18.

Delivery across cell plasma membranes

      
Application Number 17337177
Grant Number 12195748
Status In Force
Filing Date 2021-06-02
First Publication Date 2021-10-21
Grant Date 2025-01-14
Owner Avectas Limited (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

Delivering a payload across a plasma membrane of a cell includes providing a population of cells and contacting the population of cells with a volume of an aqueous solution. The aqueous solution includes the payload and alcohol content greater than 5 percent concentration. The volume of the aqueous solution may be a function of exposed surface area of the population of cells, or may be a function of a number of cells in the population of cells. Related compositions, apparatus, systems, techniques, and articles are also described.

IPC Classes  ?

  • C12N 15/89 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
  • A61K 31/473 - QuinolinesIsoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
  • A61K 31/7115 - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
  • A61K 31/721 - Dextrans
  • A61P 43/00 - Drugs for specific purposes, not provided for in groups
  • B05B 1/02 - Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops
  • B05B 7/24 - Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas with means, e.g. a container, for supplying liquid or other fluent material to a discharge device
  • C12M 1/12 - Apparatus for enzymology or microbiology with sterilisation, filtration, or dialysis means
  • C12M 1/26 - Inoculator or sampler
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/077 - Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells
  • C12N 5/0775 - Mesenchymal stem cellsAdipose-tissue derived stem cells
  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

19.

ENGINEERING OF DENDRITIC CELLS FOR GENERATION OF VACCINES AGAINST SARS-COV-2

      
Application Number IB2021000161
Publication Number 2021/191678
Status In Force
Filing Date 2021-03-23
Publication Date 2021-09-30
Owner AVECTAS LIMITED (Ireland)
Inventor
  • O'Dea, Shirley
  • Maguire, Michael

Abstract

The invention relates to methods of engineering cells (e.g., dendritic cells (DCs)) for vaccinations (e.g., COVID-19) using ethanol-based transient cell membrane permeabilization. Related methods, compositions, apparatus, systems, and articles as described and/or illustrated herein.

IPC Classes  ?

  • C12N 5/0784 - Dendritic cellsProgenitors thereof
  • A61K 35/15 - Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cellsMyeloid precursor cellsAntigen-presenting cells, e.g. dendritic cells
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • C07K 14/165 - Coronaviridae, e.g. avian infectious bronchitis virus

20.

CELL ENGINEERING PLATFORM

      
Application Number 17337294
Status Pending
Filing Date 2021-06-02
First Publication Date 2021-09-16
Owner AVECTAS LIMITED (Ireland)
Inventor Maguire, Michael

Abstract

The current subject matter provides a cell engineering platform of a diagnostic and clinical use scale for vector-free and/or viral delivery of payload/cargo compounds and compositions into non-adherent cells. The platform achieves delivery to a large number of cells quickly in a closed system. Related apparatus, systems, techniques, articles and compositions are also described.

IPC Classes  ?

  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

21.

CELL ENGINEERING PLATFORM

      
Application Number 17059769
Status Pending
Filing Date 2019-05-31
First Publication Date 2021-08-26
Owner AVECTAS LIMITED (Ireland)
Inventor Maguire, Michael

Abstract

The current subject matter provides a cell engineering platform of a diagnostic and clinical use scale for vector-free and/or viral delivery of payload/cargo compounds and compositions into non-adherent cells. The platform achieves delivery to a large number of cells quickly in a closed system. Related apparatus, systems, techniques, articles and compositions are also described.

IPC Classes  ?

  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

22.

ENGINEERING OF IMMUNE CELLS FOR EX VIVO CELL THERAPY APPLICATIONS

      
Application Number 17012748
Status Pending
Filing Date 2020-09-04
First Publication Date 2021-08-19
Owner Avectas Limited (Ireland)
Inventor
  • O'Dea, Shirley
  • Maguire, Michael

Abstract

The invention provides a solution to the problem of transfecting non-adherent cells. Methods and compositions containing ethanol and an isotonic salt solution are used for delivery of compounds and compositions to non-adherent cells, e.g. T cells.

IPC Classes  ?

  • C12N 15/85 - Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
  • C07K 14/705 - ReceptorsCell surface antigensCell surface determinants
  • C12N 5/078 - Cells from blood or from the immune system
  • A61K 35/17 - LymphocytesB-cellsT-cellsNatural killer cellsInterferon-activated or cytokine-activated lymphocytes

23.

ENGINEERING OF IMMUNE CELLS FOR EX VIVO CELL THERAPY APPLICATIONS

      
Document Number 03150095
Status Pending
Filing Date 2020-09-04
Open to Public Date 2021-03-11
Owner AVECTAS LIMITED (Ireland)
Inventor
  • O'Dea, Shirley
  • Maguire, Michael

Abstract

The invention provides a solution to the problem of transfecting non-adherent cells. Methods and compositions containing ethanol and an isotonic salt solution are used for delivery of compounds and compositions to non-adherent cells, e.g. T cells.

IPC Classes  ?

  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • C07K 14/725 - T-cell receptors
  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

24.

Delivery across cell plasma membranes

      
Application Number 17092161
Grant Number 11332757
Status In Force
Filing Date 2020-11-06
First Publication Date 2021-03-11
Grant Date 2022-05-17
Owner Avectas Limited (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

Delivering a payload across a plasma membrane of a cell includes providing a population of cells and contacting the population of cells with a volume of an aqueous solution. The aqueous solution includes the payload and alcohol content greater than 5 percent concentration. The volume of the aqueous solution may be a function of exposed surface area of the population of cells, or may be a function of a number of cells in the population of cells. Related compositions, apparatus, systems, techniques, and articles are also described.

IPC Classes  ?

  • C12N 15/89 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
  • A61K 31/7115 - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
  • B05B 7/24 - Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas with means, e.g. a container, for supplying liquid or other fluent material to a discharge device
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/077 - Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells
  • C12N 5/0775 - Mesenchymal stem cellsAdipose-tissue derived stem cells
  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
  • B05B 1/02 - Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops

25.

ENGINEERING OF IMMUNE CELLS FOR EX VIVO CELL THERAPY APPLICATIONS

      
Application Number IB2020058272
Publication Number 2021/044373
Status In Force
Filing Date 2020-09-04
Publication Date 2021-03-11
Owner AVECTAS LIMITED (Ireland)
Inventor
  • O'Dea, Shirley
  • Maguire, Michael

Abstract

The invention provides a solution to the problem of transfecting non-adherent cells. Methods and compositions containing ethanol and an isotonic salt solution are used for delivery of compounds and compositions to non-adherent cells, e.g. T cells.

IPC Classes  ?

  • C07K 14/725 - T-cell receptors
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

26.

Delivery across cell plasma membranes

      
Application Number 16841236
Grant Number 11447798
Status In Force
Filing Date 2020-04-06
First Publication Date 2021-02-25
Grant Date 2022-09-20
Owner Avectas Limited (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

Delivering a payload across a plasma membrane of a cell includes providing a population of cells and contacting the population of cells with a volume of an aqueous solution. The aqueous solution includes the payload and alcohol content greater than 5 percent concentration. The volume of the aqueous solution may be a function of exposed surface area of the population of cells, or may be a function of a number of cells in the population of cells. Related compositions, apparatus, systems, techniques, and articles are also described.

IPC Classes  ?

  • C12N 15/89 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • A61K 31/7115 - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
  • B05B 1/02 - Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops
  • B05B 7/24 - Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas with means, e.g. a container, for supplying liquid or other fluent material to a discharge device
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
  • C12N 5/077 - Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells
  • C12N 5/0775 - Mesenchymal stem cellsAdipose-tissue derived stem cells
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

27.

DELIVERY ACROSS CELL PLASMA MEMBRANES

      
Application Number 16841093
Status Pending
Filing Date 2020-04-06
First Publication Date 2021-02-25
Owner Avectas Limited (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

Delivering a payload across a plasma membrane of a cell includes providing a population of cells and contacting the population of cells with a volume of an aqueous solution. The aqueous solution includes the payload and alcohol content greater than 5 percent concentration. The volume of the aqueous solution may be a function of exposed surface area of the population of cells, or may be a function of a number of cells in the population of cells. Related compositions, apparatus, systems, techniques, and articles are also described.

IPC Classes  ?

  • C12N 15/89 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • A61K 31/7115 - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
  • B05B 7/24 - Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas with means, e.g. a container, for supplying liquid or other fluent material to a discharge device
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
  • C12N 5/077 - Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells
  • C12N 5/0775 - Mesenchymal stem cellsAdipose-tissue derived stem cells
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

28.

METHODS OF VIRAL DELIVERY TO A POPULATION OF CELLS

      
Document Number 03142327
Status Pending
Filing Date 2020-05-30
Open to Public Date 2020-12-03
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The invention provides a method of viral transfection of cells.

IPC Classes  ?

  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12N 15/86 - Viral vectors
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

29.

METHODS OF VIRAL DELIVERY TO A POPULATION OF CELLS

      
Application Number IB2020055148
Publication Number 2020/240513
Status In Force
Filing Date 2020-05-30
Publication Date 2020-12-03
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The invention provides a method of viral transfection of cells.

IPC Classes  ?

  • C12N 15/86 - Viral vectors
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave

30.

Payload delivery across cell membranes using continuous flow fluidic system

      
Application Number 16631346
Grant Number 12104166
Status In Force
Filing Date 2018-07-18
First Publication Date 2020-07-09
Grant Date 2024-10-01
Owner Avectas Limited (Ireland)
Inventor Maguire, Michael

Abstract

Methods, systems, processes, and apparatuses are provided for delivery across cell membranes. In one aspect, an apparatus includes a substrate including a mixing channel, a process chamber, and a dilution channel to perform delivery of the payload to across the cell membranes. In another aspect, a system includes reservoirs for a cell suspension, a delivery solution, and a stop solution connected to a pump. The system further includes an agitator, a heater, a temperature controller, and a controller to operate the system. In yet another aspect, cells in suspension are mixed with a delivery solution in a microfluidic mixing chip. The delivery solution includes a permeabilization agent to cause permeabilization of the cells, allowing delivery of a payload from the delivery solution to the cells across the cell membranes.

IPC Classes  ?

  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells

31.

Electrospray catheter

      
Application Number 16624986
Grant Number 11801364
Status In Force
Filing Date 2018-06-29
First Publication Date 2020-07-09
Grant Date 2023-10-31
Owner Avectas Limited (Ireland)
Inventor
  • Maguire, Michael
  • Finnegan, Shane

Abstract

An apparatus includes a catheter, and an electrode and methods of delivering molecules to eukaryotic cells using such an apparatus. The catheter defines a fluidic channel and has a distal opening. The electrode is within the fluidic channel and is spaced a distance from the distal opening of the catheter. The catheter is arranged to prevent direct contact between any electrode of the apparatus and tissue. Related apparatus, systems, techniques and articles are also described.

IPC Classes  ?

  • A61M 25/01 - Introducing, guiding, advancing, emplacing or holding catheters
  • A61M 25/00 - CathetersHollow probes
  • B05B 5/00 - Electrostatic spraying apparatusSpraying apparatus with means for charging the spray electricallyApparatus for spraying liquids or other fluent materials by other electric means
  • B05B 5/16 - Arrangements for supplying liquids or other fluent material
  • A61M 25/06 - Body-piercing guide needles or the like
  • A61M 25/09 - Guide wires

32.

Miscellaneous Design

      
Serial Number 88879529
Status Registered
Filing Date 2020-04-20
Registration Date 2022-01-11
Owner Avectas Limited (Ireland)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Stem cells for research purposes Pharmaceutical preparations for the treatment of immune-oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; stem cells for medical purposes; living cells for medical use Scientific apparatus and instruments, namely, scientific apparatus and instruments for the transfer of biological molecules into living cells, namely, a transfection system comprised of a preinstalled software controller for operating the transfection system, transfection chamber, tubes, filters, connectors, bags, andreagents; replacement parts and fittings for the aforesaid goods Surgical apparatus and instruments; medical apparatus and instruments for delivery of macro molecules to the mouth, nose, airway, lungs, namely, leukapheresis,plasmapheresis and extracorporeal photopheresis machines; replacement parts andfittings for the aforesaid goods Scientific and technological services, namely, research and engineering processdesign services in the field of pharmaceuticals, tissue engineering and regenerative medicine; analysis of industrial fluids and scientific research services; medical and scientific research; pharmaceutical research and development; and clinical testing, namely, conducting clinical trials for others in the field of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy;development of probes, reagents and bioassays for industrial, clinical, and scientific purposes; advisory, consultancy and information services relating to theprovision of the aforesaid

33.

Miscellaneous Design

      
Application Number 018225475
Status Registered
Filing Date 2020-04-14
Registration Date 2020-09-08
Owner Avectas Limited (Ireland)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Stem cells for research purposes. Pharmaceutical preparations for the treatment of immune-oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; stem cells for medical purposes; living cells for medical use. Scientific apparatus and instruments, namely, scientific apparatus and instruments for the transfer of biological molecules into living cells; measuring apparatus and instruments, namely, pressure measuring apparatus; probes for scientific purposes, namely, ultrasound probes, not for medical use; bioassay apparatus, namely, pressure measuring apparatus for use in bioassay techniques other than medical; replacement parts and fittings for the aforesaid goods. Surgical apparatus and instruments; medical apparatus and instruments for delivery of macro molecules to the mouth, nose, airway, lungs; veterinary apparatus and instruments, namely, catheter for veterinary purposes; medical and surgical probes; probes for medical use and medical diagnostic purposes; medical heartbeat measuring apparatus for use in bioassay techniques; replacement parts and fittings for the aforesaid goods; measuring apparatus and instruments, namely, heartbeat measuring apparatus. Scientific and technological services, namely, research and design in the field of pharmaceutics, tissue engineering and regenerative medicine; analysis of industrial fluids and scientific research services; medical and scientific research; pharmaceutical research and development, and clinical testing, namely, conducting clinical trials for others in the field of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of probes, reagents and bioassays for industrial and scientific purposes; advisory, consultancy and information services relating to the provision of the aforesaid.

34.

Vector-free intracellular delivery by reversible permeabilization

      
Application Number 16471466
Grant Number 11981915
Status In Force
Filing Date 2017-12-21
First Publication Date 2020-02-27
Grant Date 2024-05-14
Owner Avectas Limited (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The invention provides a solution to the problem of transfecting non-adherent cells. Devices and delivery compositions containing ethanol and an isotonic salt solution are used for delivery of compounds and compositions to non-adherent cells.

IPC Classes  ?

  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • B01J 19/00 - Chemical, physical or physico-chemical processes in generalTheir relevant apparatus
  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
  • C07K 14/725 - T-cell receptors
  • C12M 1/00 - Apparatus for enzymology or microbiology
  • C12M 1/32 - Inoculator or sampler multiple field or continuous type
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus
  • C12M 3/02 - Tissue, human, animal or plant cell, or virus culture apparatus with means providing suspensions
  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
  • C12N 13/00 - Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

35.

CELL ENGINEERING PLATFORM

      
Application Number IB2019054555
Publication Number 2019/229722
Status In Force
Filing Date 2019-05-31
Publication Date 2019-12-05
Owner AVECTAS LIMITED (Ireland)
Inventor Mcguire, Michael

Abstract

The current subject matter provides a cell engineering platform of a diagnostic and clinical use scale for vector -free and/or viral delivery of payload/cargo compounds and compositions into non-adherent cells, lire platform achieves delivery to a large number of cells quickly in a closed system. Related apparatus, systems, techniques, articles and compositions are also described.

IPC Classes  ?

  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12N 13/00 - Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

36.

SOLUPORE

      
Serial Number 88509550
Status Registered
Filing Date 2019-07-11
Registration Date 2020-12-01
Owner AVECTAS LIMITED (Ireland)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

stem cells for research purposes Pharmaceutical preparations for the treatment of cancer, autoimmune disease, rare diseases, viruses, and for use in cell transplantation and engineered cells; stem cells for medical purposes; living cells for medical use Scientific apparatus and instruments, namely, scientific apparatus and instruments for the transfer of biological molecules into living cells for the development of cell and gene therapy products; probes for scientific purposes; bioassay apparatus including immune panels; measuring apparatus and instruments, namely, ex-vivo assays for characterization of engineering cells or viruses, other than medical; parts and fittings for the aforesaid goods Surgical apparatus and instruments, medical apparatus and instruments for the modification of cells for near-patient use; medical apparatus and instruments for the modification of cells for near-patient use; measuring apparatus and instruments for bioassay techniques for medical purposes; parts and fittings for the aforesaid goods Scientific and technological services, namely, research and design in the field of process development services for cell and gene therapy products; industrial analysis and research services in the field of cell and gene therapy, and drug delivery; medical, scientific and pharmaceutical research and development, and clinical testing, in the field of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of probes, reagents and bioassays for industrial and scientific purposes; advisory, consultancy and information services in the fields of biotechnology, pharmaceutical research, laboratory testing, pharmacogenetics, clinical trials, development and genetic science

37.

Vector-free delivery of gene editing proteins and compositions to cells and tissues

      
Application Number 16067431
Grant Number 11827899
Status In Force
Filing Date 2016-12-22
First Publication Date 2019-06-27
Grant Date 2023-11-28
Owner Avectas Limited (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The present subject matter provides a method for delivering a gene editing composition across a plasma membrane of a cell. Related apparatus, system, techniques, compositions, and articles are also described.

IPC Classes  ?

  • C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression
  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • C12N 9/22 - Ribonucleases
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
  • B01L 5/00 - Gas handling apparatus
  • C12N 15/11 - DNA or RNA fragmentsModified forms thereof
  • A61K 31/70 - CarbohydratesSugarsDerivatives thereof

38.

PAYLOAD DELIVERY ACROSS CELL MEMBRANES USING CONTINUOUS FLOW FLUIDIC SYSTEM

      
Application Number IB2018000909
Publication Number 2019/016600
Status In Force
Filing Date 2018-07-18
Publication Date 2019-01-24
Owner AVECTAS LIMITED (Ireland)
Inventor Maguire, Michael

Abstract

Methods, systems, processes, and apparatuses are provided for delivery across cell membranes. In one aspect, an apparatus includes a substrate including a mixing channel, a process chamber, and a dilution channel to perform delivery of the payload to across the cell membranes. In another aspect, a system includes reservoirs for a cell suspension, a delivery solution, and a stop solution connected to a pump. The system further includes an agitator, a heater, a temperature controller, and a controller to operate the system. In yet another aspect, cells in suspension are mixed with a delivery solution in a microfluidic mixing chip. The delivery solution includes a permeabilization agent to cause permeabilization of the cells, allowing delivery of a payload from the delivery solution to the cells across the cell membranes.

39.

ELECTROSPRAY CATHETER

      
Application Number IB2018000831
Publication Number 2019/002942
Status In Force
Filing Date 2018-06-29
Publication Date 2019-01-03
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Maguire, Michael
  • Finnegan, Shane

Abstract

An apparatus includes a catheter, and an electrode and methods of delivering molecules to eukaryotic cells using such an apparatus. The catheter defines a fluidic channel and has a distal opening. The electrode is within the fluidic channel and is spaced a distance from the distal opening of the catheter. The catheter is arranged to prevent direct contact between any electrode of the apparatus and tissue. Related apparatus, systems, techniques and articles are also described.

IPC Classes  ?

  • A61M 15/02 - Inhalators with activated or ionized gasesOzone-inhalators
  • A61M 25/00 - CathetersHollow probes
  • B05B 5/00 - Electrostatic spraying apparatusSpraying apparatus with means for charging the spray electricallyApparatus for spraying liquids or other fluent materials by other electric means

40.

HOT MELT ELECTROSPINNING

      
Application Number IB2018000764
Publication Number 2018/234863
Status In Force
Filing Date 2018-06-22
Publication Date 2018-12-27
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Finnegan, Shane
  • Hendy, Gillian
  • Maguire, Michael

Abstract

Systems, devices, and methods for electro spinning are provided. For example, a system includes a collector including load sensors attached thereto, the collector configured to receive an extruded polymer; and an electro spinning melt head assembly positioned above the collector and configured to extrude the polymer. The electro spinning melt head assembly and/or the collector is configured to move. The melt head assembly includes a syringe assembly and at least one heating element configured to supply heat to the syringe assembly. The syringe assembly includes: a syringe including a passage extending from a proximal end, the passage configured to receive the polymer, and a nozzle configured to allow polymer to pass therethrough.

IPC Classes  ?

  • D01D 5/00 - Formation of filaments, threads, or the like

41.

VECTOR-FREE INTRACELLULAR DELIVERY TO NON-ADHERENT CELLS BY REVERSIBLE PERMEABILIZATION

      
Document Number 03047904
Status Pending
Filing Date 2017-12-21
Open to Public Date 2018-06-28
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The invention provides a solution to the problem of transfecting non-adherent cells. Devices and delivery compositions containing ethanol and an isotonic salt solution are used for delivery of compounds and compositions to non-adherent cells.

IPC Classes  ?

  • A61K 31/00 - Medicinal preparations containing organic active ingredients
  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus
  • C12M 3/02 - Tissue, human, animal or plant cell, or virus culture apparatus with means providing suspensions
  • C12N 13/00 - Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
  • C12N 15/00 - Mutation or genetic engineeringDNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purificationUse of hosts therefor
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

42.

VECTOR-FREE INTRACELLULAR DELIVERY BY REVERSIBLE PERMEABILISATION

      
Application Number IB2017001713
Publication Number 2018/115973
Status In Force
Filing Date 2017-12-21
Publication Date 2018-06-28
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The invention provides a solution to the problem of transfecting non-adherent cells. Devices and delivery compositions containing ethanol and an isotonic salt solution are used for delivery of compounds and compositions to non-adherent cells.

IPC Classes  ?

  • C12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus
  • C12M 3/02 - Tissue, human, animal or plant cell, or virus culture apparatus with means providing suspensions
  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • C12N 15/00 - Mutation or genetic engineeringDNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purificationUse of hosts therefor
  • C12N 13/00 - Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
  • A61K 31/00 - Medicinal preparations containing organic active ingredients

43.

ADAPTIVE ELECTROSPRAY DEVICE

      
Application Number IB2017001236
Publication Number 2018/042256
Status In Force
Filing Date 2017-08-31
Publication Date 2018-03-08
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Maguire, Michael
  • Finnegan, Shane

Abstract

The current subject matter includes an adaptive electrospray device that creates consistent output when operating in atmosphere (e.g., not a vacuum). For example, the current subject matter includes an adaptive system that can monitor two current reference points (at the emitter and counter-electrode, respectively), determine a change in emitter current that will account for the parasitic losses, and adjust the emitter current accordingly. In addition, the current subject matter includes a high- throughput adaptive electrospray device having an array of emitters that rapidly switches the electrical potential of different emitters in an array on and off at a predetermined sequence that mitigates or eliminates interference from neighboring emitters. Related apparatus, systems, techniques and articles are also described.

IPC Classes  ?

  • B05B 1/14 - Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means with multiple outlet openingsNozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means with strainers in or outside the outlet opening
  • B05B 12/08 - Arrangements for controlling deliveryArrangements for controlling the spray area responsive to condition of liquid or other fluent material discharged, of ambient medium or of target
  • B05B 12/18 - Arrangements for controlling deliveryArrangements for controlling the spray area for controlling the spray area using fluids, e.g. gas streams
  • B05B 5/025 - Discharge apparatus, e.g. electrostatic spray guns
  • B05B 1/26 - Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means with means for mechanically breaking-up or deflecting the jet after discharge, e.g. with fixed deflectorsBreaking-up the discharged liquid or other fluent material by impinging jets

44.

Delivery across cell plasma membranes

      
Application Number 15521192
Grant Number 10612042
Status In Force
Filing Date 2015-10-23
First Publication Date 2017-12-14
Grant Date 2020-04-07
Owner Avectas Limited (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

Delivering a payload across a plasma membrane of a cell includes providing a population of cells and contacting the population of cells with a volume of an aqueous solution. The aqueous solution includes the payload and alcohol content greater than 5 percent concentration. The volume of the aqueous solution may be a function of exposed surface area of the population of cells, or may be a function of a number of cells in the population of cells. Related compositions, apparatus, systems, techniques, and articles are also described.

IPC Classes  ?

  • A61K 31/70 - CarbohydratesSugarsDerivatives thereof
  • C12N 15/89 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • A61K 31/7115 - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
  • B05B 7/24 - Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas with means, e.g. a container, for supplying liquid or other fluent material to a discharge device
  • C12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave
  • C12N 5/00 - Undifferentiated human, animal or plant cells, e.g. cell linesTissuesCultivation or maintenance thereofCulture media therefor
  • C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
  • C12N 5/077 - Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells
  • C12N 5/0775 - Mesenchymal stem cellsAdipose-tissue derived stem cells
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • B05B 1/02 - Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops

45.

SOLUPORE

      
Application Number 017099821
Status Registered
Filing Date 2017-08-14
Registration Date 2018-01-02
Owner Avectas Limited (Ireland)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Pharmaceutical preparations; stem cells; living cells for medical use. Scientific apparatus and instruments, including scientific apparatus and instruments for the transfer of biological molecules into living cells; measuring apparatus and instruments; probes for scientific purposes; bioassay apparatus; measuring apparatus for use in bioassay techniques (other than medical); parts and fittings for the aforesaid goods in class 9. Surgical, medical, and veterinary apparatus and instruments; medical and surgical probes; probes for medical use and medical diagnostic purposes; measuring apparatus and instruments for use in bioassay techniques (medical); parts and fittings for the aforesaid included in class 10. Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical, scientific and pharmaceutical research and development, and clinical testing, in the field of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of probes, reagents and bioassays for industrial and scientific purposes; advisory, consultancy and information services relating to the provision of the aforesaid.

46.

VECTOR-FREE DELIVERY OF GENE EDITING PROTEINS AND COMPOSITIONS TO CELLS AND TISSUES

      
Document Number 03009715
Status Pending
Filing Date 2016-12-22
Open to Public Date 2017-07-06
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The present subject matter provides a method for delivering a gene editing composition across a plasma membrane of a cell. Related apparatus, systems, techniques, compositions, and articles are also described.

IPC Classes  ?

  • C12M 1/00 - Apparatus for enzymology or microbiology
  • C12N 9/22 - Ribonucleases
  • C12N 15/09 - Recombinant DNA-technology
  • C12N 15/11 - DNA or RNA fragmentsModified forms thereof
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
  • C12N 15/90 - Stable introduction of foreign DNA into chromosome

47.

VECTOR-FREE DELIVERY OF GENE EDITING PROTEINS AND COMPOSITIONS TO CELLS AND TISSUES

      
Application Number IB2016001895
Publication Number 2017/115128
Status In Force
Filing Date 2016-12-22
Publication Date 2017-07-06
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

The present subject matter provides a method for delivering a gene editing composition across a plasma membrane of a cell. Related apparatus, systems, techniques, compositions, and articles are also described.

IPC Classes  ?

  • C12N 9/22 - Ribonucleases
  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

48.

DELIVERY ACROSS CELL PLASMA MEMBRANES

      
Document Number 02965509
Status In Force
Filing Date 2015-10-23
Open to Public Date 2016-04-28
Grant Date 2023-03-14
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

Delivering a payload across a plasma membrane of a cell includes providing a population of cells and contacting the population of cells with a volume of an aqueous solution. The aqueous solution includes the payload and alcohol content greater than 5 percent concentration. The volume of the aqueous solution may be a function of exposed surface area of the population of cells, or may be a function of a number of cells in the population of cells. Related compositions, apparatus, systems, techniques, and articles are also described.

IPC Classes  ?

  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61M 37/00 - Other apparatus for introducing media into the bodyPercutany, i.e. introducing medicines into the body by diffusion through the skin
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
  • C12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus
  • C12N 5/07 - Animal cells or tissues
  • C12N 5/071 - Vertebrate cells or tissues, e.g. human cells or tissues
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C12N 15/87 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

49.

DELIVERY ACROSS CELL PLASMA MEMBRANES

      
Application Number US2015057247
Publication Number 2016/065341
Status In Force
Filing Date 2015-10-23
Publication Date 2016-04-28
Owner AVECTAS LIMITED (Ireland)
Inventor
  • Maguire, Michael
  • O'Dea, Shirley

Abstract

Delivering a payload across a plasma membrane of a cell includes providing a population of cells and contacting the population of cells with a volume of an aqueous solution. The aqueous solution includes the payload and alcohol content greater than 5 percent concentration. The volume of the aqueous solution may be a function of exposed surface area of the population of cells, or may be a function of a number of cells in the population of cells. Related compositions, apparatus, systems, techniques, and articles are also described.

IPC Classes  ?

  • A61K 31/7115 - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
  • C12N 1/22 - Processes using, or culture media containing, cellulose or hydrolysates thereof
  • C12N 15/85 - Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

50.

AVECTAS

      
Application Number 014571897
Status Registered
Filing Date 2015-09-17
Registration Date 2016-02-16
Owner Avectas Limited (Ireland)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 10 - Medical apparatus and instruments
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Pharmaceutical preparations; stem cells; living cells for medical use. Scientific apparatus and instruments, including scientific apparatus and instruments for the transfer of biological molecules into living cells; measuring apparatus and instruments; probes for scientific purposes; bioassay apparatus; measuring apparatus for use in bioassay techniques (other than medical); parts and fittings for the aforesaid goods in class 9. Surgical, medical, and veterinary apparatus and instruments; medical and surgical probes; probes for medical use and medical diagnostic purposes; measuring apparatus and instruments for use in bioassay techniques (medical); parts and fittings for the aforesaid included in class 10. Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical, scientific and pharmaceutical research and development, and clinical testing, in the field of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of probes, reagents and bioassays for industrial and scientific purposes;  advisory, consultancy and information services relating to the provision of the aforesaid.